Daiichi Sankyo develops and markets pharmaceuticals. The Company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and other aspects. It serves customers in the United States and internationally.
Daiichi Sankyo has 242 Twitter Followers. The number of followers has increased 2.5% month over month and increased 9.2% quarter over quarter
Daiichi Sankyo has 200 Facebook Likes. The number of likes has increased 5.8% month over month and increased 11.5% quarter over quarter